Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 MEDLINE search strategy

From: Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis

1 exp Mass Screening/
2 limit 1 to (english language and humans)
3 screen*.mp.
4 limit 3 to (english language and humans)
5 exp Cost-Benefit Analysis/ or cost-effective*.mp
6 limit 5 to (english language and humans)
7 economic evaluation.mp.
8 limit 7 to (english language and humans)
9 2 or 4
12 6 or 8
11 9 and 10